[{"id":"a339dfb3-6028-4f3a-ac08-8ffbfee76968","acronym":"","url":"https://clinicaltrials.gov/study/NCT05703854","created_at":"2023-01-30T18:59:49.752Z","updated_at":"2024-07-02T16:35:07.538Z","phase":"Phase 1/2","brief_title":"Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma","source_id_and_acronym":"NCT05703854","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • CAR.70/IL15-transduced CB-NK cells"],"overall_status":"Recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 03/29/2023","start_date":" 03/29/2023","primary_txt":" Primary completion: 09/30/2025","primary_completion_date":" 09/30/2025","study_txt":" Completion: 09/30/2027","study_completion_date":" 09/30/2027","last_update_posted":"2024-04-25"}]